A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma Academic Article uri icon

Overview

MeSH Major

  • Lymphoma, Large B-Cell, Diffuse
  • Rituximab
  • Thalidomide

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2016.255

PubMed ID

  • 27654851

Additional Document Info

start page

  • 241

end page

  • 244

volume

  • 31

number

  • 1